TTRX NASDAQ
Turn Therapeutics Inc.
1W: +6.7%
1M: +37.9%
3M: +73.3%
YTD: +184.2%
$13.33
+0.02 (+0.15%)
Weekly Expected Move ±18.7%
$8
$11
$13
$16
$18
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships1
As Filer
counterparties named
1
As Counterparty
mentioned by others
1
Rel. Types
2022-12-08
Earliest Filing
2025-10-28
Latest Filing
partner: 1
Counterparties (Filed by TTRX)
1 relationshipsCompanies named in TTRX's SEC 8-K filings as business counterparties.
Mentioned As Counterparty
1 mentionsOther companies that named TTRX in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-10 | Regulation FD; Exhibits | View | |
| 2026-09-09 | Regulation FD; Exhibits | View | |
| 2026-08-18 | Unregistered Equity Sales | View | |
| 2026-08-17 | Regulation FD; Exhibits | View | |
| 2026-08-12 | Earnings Release; Exhibits | View | |
| 2026-07-28 | Regulation FD; Exhibits | View | |
| 2026-07-07 | Regulation FD; Exhibits | View | |
| 2026-06-03 | Regulation FD; Exhibits | View | |
| 2026-06-01 | Regulation FD; Exhibits | View | |
| 2026-05-27 | Regulation FD; Exhibits | View | |
| 2026-05-19 | Regulation FD; Exhibits | View | |
| 2026-05-18 | Regulation FD; Exhibits | View | |
| 2026-03-31 | Earnings Release; Exhibits | View | |
| 2026-03-24 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement | View |
| 2026-02-17 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-02-09 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-01-12 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-01-07 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-12 | Regulation FD Disclosure; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR